Wagstaff Laboratory
Cancer Targeting and Nuclear Therapeutics
Welcome to the Wagstaff Lab
Breast cancer remains one of the leading causes of death in Australia, with current treatments often causing debilitating unwanted toxic side effects. Our lab aims to determine the underlying cellular differences between cancer and normal cells, and to understand the causes of these changes, so that we can develop new drugs and delivery agents to target them specifically.
We're part of the Monash Biomedicine Discovery Institute, and a member of the Cancer and Infection & Immunity Programs, and the Department of Biochemistry and Molecular Biology.
Dr Kylie Wagstaff
My global research connections, partners and funding can be viewed on my Monash Research Profile.
If you are a student interested in doing research in our lab, visit Supervisor Connect.
Click the links below to connect with me on ORCID, Google Scholar and LinkedIn.
Our research
By determining the underlying cellular differences between cancer and normal cells, we are able to understand the causes of these changes and to develop new drugs and delivery agents to target them specifically.
Similarly, infectious diseases such as those caused by viruses and cellular stress conditions often rely upon or generate changes in the subcellular targeting of various proteins, particularly those involved in transport between the cytoplasm and the nucleus. We identify these protein interactions and harness them to develop novel anti-viral drugs and to uncover the cellular pathways, which underpin these important conditions.
Lab members
We are committed to excellence in research.
Join Our Lab
We're always interested in collaborating with bright and motivated researchers, clinicians and industry. Whether you want to research, study or partner with us to accelerate our discoveries, find out about the work we do.